PRINCETON, NJ, July 14, 2014 - Zycus, a world leader in Procurement Technology solutions across the source-to-pay cycle, announced today that a leading pharmaceuticals manufacturer company is adopting its Spend Analysis Solution.
The UK based firm has a mission of enabling people with life-altering conditions to lead better lives and focuses in particular on treatments with potential to have immediate and tangible impacts for patients with unmet needs.
“Every time our procurement team finds a way to save money, it enables our company to invest more in its core corporate mission of improving quality of life for patients with rare medical conditions,” says the CPO. “Through a proof-of-concept, Zycus has demonstrated to us a strong capability and deep expertise for rapidly and accurately classifying, enriching and transforming ERP and other spend transaction data into detailed, procurement-centric views. We expect to use the Zycus Spend Analysis solution to identify real savings and other performance improvement opportunities much faster and more efficiently than we have been able to do in the past.”
Through a proof-of-concept, Zycus has demonstrated to us a strong capability and deep expertise for rapidly and accurately classifying, enriching and transforming ERP and other spend transaction data into detailed, procurement-centric views.
“A big part of the value in process automation,” observes Zycus founder and CEO Aatish Dedhia, “is enabling corporate enterprises to focus on the really important things, which, in this association, is making real impacts on patient quality of life. By partnering with Zycus for Spend Analysis, the company is not only accessing the world’s fastest and most advanced AI-powered spend classification engine but is also leveraging the deep domain expertise that Zycus has acquired in analyzing and mining pharmaceuticals corporate spending data for real performance improvement opportunities.”
Manager- Public Relations, Zycus Inc.
Direct: 1 866 563 9219